Key result
Current smoking linked to worse physical functioning and bowel bother in uninsured prostate cancer patients.
Why the study?
Critical gaps remained in prostate cancer survivorship, quality of life, and health outcomes among uninsured and underrepresented men.
Cohort (n=1,328)
Modifiable health behaviors, particularly smoking and comorbidity burden, are strong drivers of survivorship disparities among uninsured and underrepresented prostate cancer patients.
Answers are grounded in this paper and cite their sources.
Smoking was associated with worse QoL in uninsured prostate cancer survivors; hypothesis-generating for cessation interventions, with prospective trials needed.
e13586 Background: The UCLA Men’s Health Study (MHS) was initiated 25 years ago to address critical gaps in prostate cancer (PCa) survivorship, quality of life(QOL), and health outcomes among uninsured and underrepresented men. MHS has collected patient-reported data across sociodemographic, physical, emotional, behavioral, and cancer-specific domains, providing an unparalleled view of survivorship patterns in a diverse, low-income, multi-ethnic PCa population. We conducted a systematic review of MHS findings to characterize long-term survivorship trends, identify determinants of QOL, and inform health-equity–focused interventions. Methods: The cohort included 1,328 participants enrolled in a program providing free PCa-related care to uninsured men in California across three periods: 2000–2008, 2009–2018, and 2019–2025, reflecting evolving treatment practices, health policy (including the Affordable Care Act), and external influences such as the COVID-19 pandemic. We evaluated longitudinal trends in patient-reported physical health, emotional well-being, and cancer-specific outcomes by enrollment period. Results: Participants included 771 enrolled PCa patients in 2000–2008, 529 in 2009–2018, and 28 in 2019–2025. Participants were predominantly < 65 years (86%), Hispanic (60%), and married/partnered (59%), and had low educational attainment (46%). Daily alcohol use declined over time (25% to 10%, p < 0.0001), and comorbidity burden decreased, with the proportion of participants with Charlson Comorbidity Index = 0 increasing from 36% to > 60% (p < 0.0001). Disease characteristics shifted, with earlier cohorts having a higher proportion of T1 disease and later cohorts showing more T2 disease, (p = 0.0004), Gleason grade distribution (p = 0.026),in later cohorts reflecting a higher proportion of intermediate/high-grade disease (GG 2–4), and pretreatment PSA levels (p < 0.0001). In multivariable analyses, current smoking was associated with worse survivorship outcomes, including lower physical functioning (β = −7.7, p = 0.028), lower SF-12 physical component scores (β = −3.2, p = 0.009), and greater bowel bother (β = −6.8, p = 0.037). Comorbidity burden was associated with poorer physical functioning (β = −5.5, p < 0.05) and worse mental health outcomes (β = −3.1, p < 0.05). Mental health outcomes were less strongly associated with age but were consistently influenced by behavioral and comorbidity factors. Conclusions: Across 25 years of follow-up, modifiable health behaviors, particularly smoking and comorbidity burden emerged as the strongest drivers of survivorship disparities among uninsured and underrepresented PCa patients These findings highlight the importance of integrating behavioral risk reduction and comorbidity management into survivorship care models to advance health equity.
No takes yet. Share an insight, caveat, or question.
Shachar et al. (2026) conducted a cohort in Prostate cancer (n=1,328). Among uninsured prostate cancer patients, current smoking was associated with lower physical functioning and greater bowel bother.
Synapse has enriched 10 related papers. Consider them for comparative context: